Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 208-217

  Hsu, Kai Wen ^a   Wang, An Ming ^a   Ping, Yueh Hsin ^a   Huang, Kuo Hung ^a,b   Huang, Tzu Ting ^a   Lee, Hsin Chen ^a   Lo, Su Shun ^a   Chi, Chin Wen ^a,b   Yeh, Tien Shun ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; C MYC PROMOTER BINDING PROTEIN 1; MESSENGER RNA; MICRORNA; MICRORNA 363; MYC PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL MIGRATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR INVASION; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE, NUDE; MICE, SCID; MICRORNAS; PHOSPHOPYRUVATE HYDRATASE; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891358116     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt285     Document Type: Article

References (50)

1. Ferlay,J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Ushijima,T. et al. (2004) Focus on gastric cancer. Cancer Cell, 5, 121-125.
3. Smith,M.G. et al. (2006) Cellular and molecular aspects of gastric cancer. World J. Gastroenterol., 12, 2979-2990.
4. Polk,D.B. et al. (2010) Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer, 10, 403-414.
5. Ray,R. et al. (1994) Human breast-carcinoma cells show correlation in expression of C-myc oncogene and the C-myc binding-protein (mbp-1). Int. J. Oncol., 5, 1433-1436.
6. Feo,S. et al. (2000) ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett., 473, 47-52.
7. Subramanian,A. et al. (2000) Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J. Biol. Chem., 275, 5958-5965.
8. Ray,R.B. et al. (1995) Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res., 55, 3747-3751.
9. Ito,S. et al. (2007) Differential expression of the human alpha-enolase gene in oral epithelium and squamous cell carcinoma. Cancer Sci., 98, 499-505.
10. Ghosh,A.K. et al. (2006) Tumor-suppressive effects of MBP-1 in nonsmall cell lung cancer cells. Cancer Res., 66, 11907-11912.
11. Takashima,M. et al. (2005) Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics, 5, 1686-1692.
12. Ghosh,A.K. et al. (2005) Carboxyl-terminal repressor domain of MBP-1 is sufficient for regression of prostate tumor growth in nude mice. Cancer Res., 65, 718-721.
13. Ejeskär,K. et al. (2005) Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer, 5, 161.
14. Hsu,K.W. et al. (2009) MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2. Mol. Biol. Cell, 20, 5127-5137.
15. Ghosh,A.K. et al. (2008) Knockdown of MBP-1 in human foreskin fibroblasts induces p53-p21 dependent senescence. PLoS One, 3, e3384.
16. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
17. Liu,C. et al. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med., 17, 211-215.
18. Garzon,R. et al. (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov., 9, 775-789.
19. Wu,W.K. et al. (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene, 29, 5761-5771.
20. Ueda,T. et al. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol., 11, 136-146.
21. Suzuki,H. et al. (2010) Methylation-associated silencing of microRNA- 34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis, 31, 2066-2073.
22. Hashimoto,Y. et al. (2010) Involvement of epigenetically silenced micro- RNA-181c in gastric carcinogenesis. Carcinogenesis, 31, 777-784.
23. Saito,Y. et al. (2009) Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene, 28, 2738-2744.
24. Steele,R. et al. (2010) MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer, 1, 381-387.
25. Hsu,K.W. et al. (2008) The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity. Mol. Cell. Biol., 28, 4829-4842.
26. Yeh,T.S. et al. (2009) The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res., 69, 5039-5048.
27. Takaishi,S. et al. (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells, 27, 1006-1020.
28. Haraguchi,N. et al. (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 24, 506-513.
29. Ji,Q. et al. (2008) Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer, 8, 266.
30. Hwang,W.L. et al. (2011) SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology, 141, 279-91, 291.e1.
31. Yu,Z. et al. (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc. Natl Acad. Sci. USA, 107, 8231-8236.
32. Georgieva,B. et al. (2012) Characterization of the uterine leiomyoma microRNAome by deep sequencing. Genomics, 99, 275-281.
33. Li,J. et al. (2010) Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res. Ther., 12, R81.
34. Takahashi,N. et al. (2012) Profiling of immune-related microRNA expression in human cord blood and adult peripheral blood cells upon proinflammatory stimulation. Eur. J. Haematol., 88, 31-38.
35. Dreher,A. et al. (2011) Differential expression of cellular microRNAs in HPV 11, -16, and -45 transfected cells. Biochem. Biophys. Res. Commun., 412, 20-25.
36. Wald,A.I. et al. (2011) Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck, 33, 504-512.
37. Ng,S.B. et al. (2011) Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma. Blood, 118, 4919-4929.
38. Zhang,Z. et al. (2011) The microRNA-processing enzyme Dicer is dispensable for somite segmentation but essential for limb bud positioning. Dev. Biol., 351, 254-265.
39. Sun,Q. et al. (2013) Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int. J. Biochem. Cell Biol., 45, 513-520.
40. Chen,T. et al. (2012) Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res., 22, 248-258.
41. Ivanovska,I. et al. (2008) Combinatorial microRNAs: working together to make a difference. Cell Cycle, 7, 3137-3142.
42. Krützfeldt,J. et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, 685-689.
43. Elmén,J. et al. (2008) LNA-mediated microRNA silencing in non-human primates. Nature, 452, 896-899.
44. Li,X. et al. (2010) Survival prediction of gastric cancer by a seven-micro- RNA signature. Gut, 59, 579-585.
45. Thiel,A. et al. (2012) Gastric cancer: basic aspects. Helicobacter, 17 (suppl. 1), 26-29.
46. Kozma,L. et al. (2001) C-myc amplification and cluster analysis in human gastric carcinoma. Anticancer Res., 21, 707-710.
47. Hsu,K.W. et al. (2012) Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression. Carcinogenesis, 33, 1459-1467.
48. Jain,M. et al. (2002) Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science, 297, 102-104.
49. Shachaf,C.M. et al. (2004) MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature, 431, 1112-1117.
50. Jiang,X.H. et al. (2003) Cyclooxygenase-2 inhibition and gastric cancer. Curr. Pharm. Des., 9, 2281-2288.